Literature DB >> 4124563

Indomethacin in breast cancer.

B A Stoll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4124563     DOI： 10.1016/s0140-6736(73)93234-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.

Authors:  O Gallo; A Franchi; L Magnelli; I Sardi; A Vannacci; V Boddi; V Chiarugi; E Masini
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  COX2 expression in high-grade breast cancer: evidence for prognostic significance in the subset of triple-negative breast cancer patients.

Authors:  Bar Chikman; Sergey Vasyanovich; Ron Lavy; Liliana Habler; Gleb Tolstov; Andronik Kapiev; Ariel Halevy; Judith Sandbank
Journal:  Med Oncol       Date:  2014-05-10       Impact factor: 3.064

Review 3.  Emergencies in oncology. Current management.

Authors:  D C Stolinsky
Journal:  West J Med       Date:  1978-09

4.  Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer.

Authors:  K J McCormick; W R Panje
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Relation of the expression of cyclooxygenase-2 in colorectal adenomas and adenocarcinomas to angiogenesis and prognosis.

Authors:  Yoon Dae Han; Young Ki Hong; Jung Gu Kang; Yoon Jung Choi; Chan Heun Park
Journal:  J Korean Soc Coloproctol       Date:  2010-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.